PRF Technologies (PRFX) Total Debt (2019 - 2025)

PRF Technologies (PRFX) recorded quarterly Total Debt of $50000.0 in Q2 2025, down 96.69% on a QoQ basis from $1.5 million in Q2 2020.

PRF Technologies (PRFX) Total Debt (2019 - 2025) Analysis & Trends

PRF Technologies has disclosed Total Debt across 3 years of filings, most recently posting $50000.0 for Q2 2025.

Quarterly Total Debt changed N/A year-over-year to $50000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $50000.0 (changed N/A YoY) and the FY2019 annual result came in at $447000.0, changed N/A from the prior year.
Total Debt eased to $50000.0 in Q2 2025, from $1.5 million in the prior quarter.
Over five years, Total Debt peaked at $50000.0 in Q2 2025 and troughed at $50000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	16.63 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	9.05 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	3.53 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	3.99 Bn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	1.51 Bn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	570.41 Mn
10	PRF Technologies	933,081.16	-2.46 Mn	-	-

Download Data